Carmen Chang Sells 3,915 Shares of NeueHealth (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) Director Carmen Chang sold 3,915 shares of the company’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $6.75, for a total transaction of $26,426.25. Following the completion of the transaction, the director owned 488,702 shares of the company’s stock, valued at $3,298,738.50. This trade represents a 0.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

NeueHealth Stock Performance

Shares of NEUE stock opened at $6.75 on Wednesday. The company has a market capitalization of $60.94 million, a PE ratio of -0.42 and a beta of 0.59. The firm has a fifty day simple moving average of $6.71 and a 200-day simple moving average of $6.73. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66.

NeueHealth (NYSE:NEUE) last announced its earnings results on Thursday, August 7th. The company reported ($1.68) earnings per share for the quarter, beating the consensus estimate of ($4.77) by $3.09. The firm had revenue of $209.08 million during the quarter, compared to analysts’ expectations of $249.50 million. Equities research analysts predict that NeueHealth, Inc. will post -9.13 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NeueHealth stock. PenderFund Capital Management Ltd. acquired a new stake in shares of NeueHealth, Inc. (NYSE:NEUE) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 29,115 shares of the company’s stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned about 0.33% of NeueHealth at the end of the most recent reporting period. 63.88% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of NeueHealth in a research note on Saturday, September 27th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, NeueHealth currently has an average rating of “Reduce” and an average target price of $7.00.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.